Wei Yuan

Wei Yuan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Gut Microbes
Verified
Journal Article
Open access
QTQin Tan
Qin Tan
XMXiao Ma
Xiao Ma
BYBing Yang
Bing Yang
YLYe Liu
Ye Liu
YXYibin Xie
Yibin Xie
JMJie Ma
Jie Ma
Intratumor microbiome shapes the immune system and influences the outcome of various tumors. Porphyromonas gingivalis (P. gingivalis), the keystone periodontal pathogen, is highly epidemically connected with pancreatic cancer (PC). However, its causative role and the underlining mechanism in promoting PC oncogenesis remain unclear. Here, we illustrated the landscape of intratumor microbiome and its bacterial correlation with oral cavity in PC patients, where P. gingivalis presented both in the oral cavity and tumor tissues. When exposed to P. gingivalis, tumor development was accelerated in orthotopic and subcutaneous PC mouse model, and the cancerous pancreas exhibited a neutrophils-dominated proinflammatory tumor microenvironment. Mechanistically, the intratumoral P. gingivalis promoted PC progression via elevating the secretion of neutrophilic chemokines and neutrophil elastase (NE). Collectively, our study disclosed the bacterial link between periodontitis and PC, and revealed a previously unrecognized mechanism of P. gingivalis in PC pathophysiology, hinting at therapeutic implications.

21 January 2016 in Protein & Cell
Verified
Journal Article
Open access
PDF file
WLWenbin Li
Wenbin Li
XZXinghua Zhang
Xinghua Zhang
YCYongkang Chen
Yongkang Chen
YXYibin Xie
Yibin Xie
JLJiancheng Liu
Jiancheng Liu
JMJie Ma
Jie Ma
Granulocyte colony-stimulating factor (G-CSF) is an essential regulator of neutrophil trafficking and is highly expressed in multiple tumors. Myeloid derived suppressor cells (MDSCs) promote neoplastic progression through multiple mechanisms by immune suppression. Despite the findings of G-CSF function in colon cancer progression, the precise mechanism of G-CSF on MDSCs regulation and its blockade effects on tumor growth remains a worthy area of investigation. In this study we observed an overexpression of G-CSF in a mouse colitis-associated cancer (CAC) model, which was consistent with the accumulation of MDSCs in mouse colon tissues. Further in vitro studies demonstrated that G-CSF could promote MDSCs survival and activation through signal transducer and activator of transcription 3 (STAT3) signaling pathway. Moreover, compared with isotype control, anti-G-CSF mAb treatment demonstrated reduced MDSC accumulation, which led to a marked decrease in neoplasm size and number in mice. Our results indicated that G-CSF is a critical regulating molecule in the migration, proliferation and function maintenance of MDSCs, which could be a potential therapeutic target for colitis-associated cancer.

28 May 2025 in Advanced Science
Verified
Journal Article
Open access
YNYanan Niu
Yanan Niu
XZXu Zhao
Xu Zhao
YLYong Li
Yong Li
XMXiaoya Ma
Xiaoya Ma
WYWeifeng Yang
Weifeng Yang
WYWei Yuan
Wei Yuan
Fusobacterium nucleatum ( Fn ) enrichment has been identified in colorectal cancer and its liver metastases. In this study, we found that Fn predominantly accumulated within colorectal cancer cells, correlating with colorectal cancer liver metastasis. Clinically, the administration of high doses of antibiotics and chemotherapeutic agents can disrupt the balance of the host microbiota. To address this clinical challenge, metronidazole (MTI) and oxaliplatin (OXA) are encapsulated within poly (lactic‐co‐glycolic acid) (PLGA) nanoparticles. Neutrophil membrane vesicles are extracted from murine bone marrow and coated with these nanoparticles (NM@PLGA‐MTI‐OXA), creating neutrophil‐mimetic nanoparticles with dual targeting capabilities for antibacterial and anticancer purposes. The neutrophil membrane coating, compared with free drugs, is found to enhance nanoparticle uptake by tumor cells, facilitating intracellular bacterial elimination and tumor cell death. Further experiments reveal that NM@PLGA‐MTI‐OXA reverses the Fn ‐induced epithelial‐mesenchymal transition (EMT) in tumor cells during metastasis and remodels the immunosuppressive microenvironment, suppressing colorectal cancer and liver metastasis development while minimizing broad‐spectrum damage to the commensal microbiota.

6 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
XZXinghua Zhang
Xinghua Zhang
XMXiao Ma
Xiao Ma
HAHuaying An
Huaying An
CXChangqing Xu
Changqing Xu
WCWenjo Cao
Wenjo Cao
JMJie Ma
Jie Ma
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Xinghua Zhang1, *, Xiao Ma1, *, Huaying An1, Changqing Xu2, Wenjo Cao3, Wei Yuan1, 4 and Jie Ma1, 4, 5 1State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2Department of Gastroenterology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China 3Department of Science, University of British Columbia, Vancouver, Canada 4Clinical Immunology Center, Chinese Academy of Medical Science, Beijing, China 5Department of Biotherapy, Beijing Hospital, National Center of Gerontology, Beijing, China *These authors are contributed equally to this work Correspondence to: Wei Yuan, email: yuanwei7568@163.com Jie Ma, email: majie@cicams.ac.cn Keywords: colorectal cancer, microRNA-125b, MCL1, G-CSF, metastasis Received: November 25, 2016 Accepted: March 27, 2017 Published: April 06, 2017

18 October 2016 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SDShun Duan
Shun Duan
BYBingran Yu
Bingran Yu
CGChunxiao Gao
Chunxiao Gao
WYWei Yuan
Wei Yuan
JMJie Ma
Jie Ma
Fujian XuFujian Xu
Fujian Xu

24 March 2025 in Exploration
Verified
Journal Article
Open access
YNYanan Niu
Yanan Niu
JFJunya Feng
Junya Feng
JMJie Ma
Jie Ma
TXTixian Xiao
Tixian Xiao
WYWei Yuan
Wei Yuan
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment (TME), has been emerging as a key participant and driving factor in cancer. Previously, due to technical issues and low biological content, little was known about the microbial community within tumors. With the development of high‐throughput sequencing technology and molecular biology techniques, it has been demonstrated that tumors harbor highly heterogeneous symbiotic microbial communities, which affect tumor progression mechanisms through various pathways, such as inducing DNA damage, activating carcinogenic pathways, and inducing an immunesuppressive environment. Faced with the harmful microbial communities in the TME, efforts have been made to develop new technologies specifically targeting the microbiome and tumor microecology. Given the success of nanotechnology in cancer diagnosis and treatment, the development of nanotechnology to regulate microscale and molecular‐scale interactions occurring in the microbiome and tumor microecology holds promise for providing new approaches for cancer therapy. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral microorganisms using nanotechnology. Additionally, this article delivers prospects for the potential clinical significance and challenges of anti‐tumor strategies against intra‐tumoral microorganisms.